{
    "eid": "2-s2.0-84899785133",
    "title": "Key binding and susceptibility of NS3/4A serine protease inhibitors against hepatitis C virus",
    "cover-date": "2014-04-28",
    "subject-areas": [
        {
            "$": "General Chemistry",
            "@code": "1600"
        },
        {
            "$": "Computer Science Applications",
            "@code": "1706"
        },
        {
            "$": "Library and Information Sciences",
            "@code": "3309"
        },
        {
            "$": "General Chemical Engineering",
            "@code": "1500"
        }
    ],
    "keywords": [],
    "authors": [
        "Arthitaya Meeprasert"
    ],
    "citedby-count": 51,
    "ref-count": 50,
    "ref-list": [
        "Hepatitis C virus infection",
        "An overview about hepatitis C: A devastating virus",
        "Current and emerging therapeutic approaches to hepatitis C infection",
        "Current therapies for chronic hepatitis C",
        "Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection",
        "Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells",
        "In vitro resistance profile of the hepatitis C virus NS3 protease inhibitor BI 201335",
        "Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)",
        "Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease",
        "Computer-assisted analysis of the interactions of macrocyclic inhibitors with wild type and mutant D168A hepatitis C virus NS3 serine protease",
        "The design and enzyme-bound crystal structure of indoline based peptidomimetic inhibitors of hepatitis C virus NS3 protease",
        "Exploring the P2 and P3 ligand binding features for Hepatitis C virus NS3 protease using some 3D QSAR techniques",
        "Understanding the structural and energetic basis of inhibitor and substrate bound to the full-length NS3/4A: Insights from molecular dynamics simulation, binding free energy calculation and network analysis",
        "Hepatitis C Viruses: Genomes and Molecular Biology",
        "Development of novel antiviral therapies for hepatitis c virus",
        "Unravelling hepatitis C virus replication from genome to function",
        "The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site",
        "Combined x-ray, NMR, and kinetic analyses reveal uncommon binding characteristics of the hepatitis C virus NS3-NS4A protease inhibitor BI 201335",
        "Inhibitors of hepatitis C virus NS3\u00b74A protease. Effect of P4 capping groups on inhibitory potency and pharmacokinetics",
        "Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1- (cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(S)-[[[(1,1-dimethylethyl)amino] carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0] hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization",
        "Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding",
        "Computational study on the drug resistance mechanism against HCV NS3/4A protease inhibitors vaniprevir and MK-5172 by the combination use of molecular dynamics simulation, residue interaction network, and substrate envelope analysis",
        "The molecular basis of drug resistance against hepatitis C virus NS3/4A protease inhibitors",
        "Refined structure of sindbis virus core protein and comparison with other chymotrypsin-like serine proteinase structures",
        "Structure and function of the hepatitis C virus NS3-NS4A serine proteinase",
        "Structure-based design of inhibitors of NS3 serine protease of hepatitis C virus",
        "Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus",
        "Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain",
        "The Amber biomolecular simulation programs",
        null,
        "A Point-Charge Force Field for Molecular Mechanics Simulations of Proteins Based on Condensed-Phase Quantum Mechanical Calculations",
        "Gaussian 03, Revision C.02",
        "Development and testing of a general Amber force field",
        "Comparison of simple potential functions for simulating liquid water",
        "Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes",
        "The effect of long-range electrostatic interactions in simulations of macromolecular crystals: A comparison of the Ewald and truncated list methods",
        "Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations",
        "Prediction of binding for a kind of non-peptic HCV NS3 serine protease inhibitors from plants by molecular docking and MM-PBSA method",
        "Effect of halogen substitutions on dUMP to stability of thymidylate synthase/dUMP/mTHF ternary complex using molecular dynamics simulation",
        "Molecular dynamic behavior and binding affinity of flavonoid analogues to the cyclin dependent kinase 6/cyclin D complex",
        "Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1",
        "Molecular insight into the specific binding of ADP-ribose to the nsP3 macro domains of chikungunya and venezuelan equine encephalitis viruses: Molecular dynamics simulations and free energy calculations",
        "Converging Free Energy Estimates: MM-PB(GB)SA Studies on the Protein-Protein Complex Ras-Raf",
        "Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models",
        "Novel macrocyclic HCV NS3 protease inhibitors derived from \u03b1-amino cyclic boronates",
        "Molecular modeling study on the resistance mechanism of HCV NS3/4A serine protease mutants R155K, A156V and D168A to TMC435",
        "Hepatitis C virus resistance to protease inhibitors",
        "Relative replication capacity and selective advantage profiles of protease inhibitor-resistant hepatitis C virus (HCV) NS3 protease mutants in the HCV genotype 1b replicon system",
        "In vitro resistance profile of the hepatitis C virus NS3/4A protease inhibitor TMC435",
        "In Silico screening for potent inhibitors against the NS3/4A protease of hepatitis C virus"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": []
}